Search research articles
Contact Us
Filters
Showing results (1041-1050 of 1,174) with videos related to
Page
of 118
Sort By:
Journal of Acquired Immune Deficiency Syndromes (1999)
|
July 23, 2008
Effectiveness of HIV/STD sexual risk reduction groups for women in substance abuse treatment programs: results of NIDA Clinical Trials Network Trial
Susan Tross, Aimee N C Campbell, Lisa R Cohen, et al.
Journal of Medicinal Chemistry
|
December 20, 2018
Discovery of N-(4-(6-Acetamidopyrimidin-4-yloxy)phenyl)-2-(2-(trifluoromethyl)phenyl)acetamide (CHMFL-FLT3-335) as a Potent FMS-like Tyrosine Kinase 3 Internal Tandem Duplication (FLT3-ITD) Mutant Selective Inhibitor for Acute Myeloid Leukemia
Xiaofei Liang, Beilei Wang, Cheng Chen, et al.
Oncotarget
|
April 15, 2017
Discovery and characterization of a novel irreversible EGFR mutants selective and potent kinase inhibitor CHMFL-EGFR-26 with a distinct binding mode
Chen Hu, Aoli Wang, Hong Wu, et al.
Oncotarget
|
January 18, 2018
Discovery of a highly selective KIT kinase primary V559D mutant inhibitor for gastrointestinal stromal tumors (GISTs)
Kailin Yu, Xuesong Liu, Zongru Jiang, et al.
The American Journal of Clinical Nutrition
|
January 25, 2020
Genetic risk, adherence to a healthy lifestyle, and type 2 diabetes risk among 550,000 Chinese adults: results from 2 independent Asian cohorts
Haoxin Li, Chiea-Chuen Khor, Junning Fan, et al.
Biology Direct
|
April 23, 2023
IGF2BP2 promotes colorectal cancer progression by upregulating the expression of TFRC and enhancing iron metabolism
Tian-Yue Liu, Chen-Chen Hu, Chen-Ying Han, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
September 12, 2025
Efficacy and safety of twice-daily accelerated hyperfractionated re-irradiation for thoracic malignancies
Victoria L Doss, Cecilia F P M de Sousa, Elaina Hales, et al.
Journal for Immunotherapy of Cancer
|
October 4, 2023
Ablative radiation alone in stage I lung cancer produces an adaptive systemic immune response: insights from a prospective stud
Khinh Ranh Voong, Peter B Illei, Bradley Presson, et al.
International Journal of Radiation Oncology, Biology, Physics
|
June 25, 2015
Importance of Local Control in Early-Stage Prostate Cancer: Outcomes of Patients With Positive Post-Radiation Therapy Biopsy Results Treated in RTOG 9408
Daniel J Krauss, Chen Hu, Jean-Paul Bahary, et al.
Acta Pharmacologica Sinica
|
May 14, 2020
Osimertinib successfully combats EGFR-negative glioblastoma cells by inhibiting the MAPK pathway
Cheng Chen, Chuan-Dong Cheng, Hong Wu, et al.
Page
of 118
Search research articles
Search
Showing results (1041-1050 of 1,174) with videos related to
Sort By:
Page
of 118
Journal of Acquired Immune Deficiency Syndromes (1999)
|
July 23, 2008
Effectiveness of HIV/STD sexual risk reduction groups for women in substance abuse treatment programs: results of NIDA Clinical Trials Network Trial
Susan Tross, Aimee N C Campbell, Lisa R Cohen, et al.
Journal of Medicinal Chemistry
|
December 20, 2018
Discovery of N-(4-(6-Acetamidopyrimidin-4-yloxy)phenyl)-2-(2-(trifluoromethyl)phenyl)acetamide (CHMFL-FLT3-335) as a Potent FMS-like Tyrosine Kinase 3 Internal Tandem Duplication (FLT3-ITD) Mutant Selective Inhibitor for Acute Myeloid Leukemia
Xiaofei Liang, Beilei Wang, Cheng Chen, et al.
Oncotarget
|
April 15, 2017
Discovery and characterization of a novel irreversible EGFR mutants selective and potent kinase inhibitor CHMFL-EGFR-26 with a distinct binding mode
Chen Hu, Aoli Wang, Hong Wu, et al.
Oncotarget
|
January 18, 2018
Discovery of a highly selective KIT kinase primary V559D mutant inhibitor for gastrointestinal stromal tumors (GISTs)
Kailin Yu, Xuesong Liu, Zongru Jiang, et al.
The American Journal of Clinical Nutrition
|
January 25, 2020
Genetic risk, adherence to a healthy lifestyle, and type 2 diabetes risk among 550,000 Chinese adults: results from 2 independent Asian cohorts
Haoxin Li, Chiea-Chuen Khor, Junning Fan, et al.
Biology Direct
|
April 23, 2023
IGF2BP2 promotes colorectal cancer progression by upregulating the expression of TFRC and enhancing iron metabolism
Tian-Yue Liu, Chen-Chen Hu, Chen-Ying Han, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
September 12, 2025
Efficacy and safety of twice-daily accelerated hyperfractionated re-irradiation for thoracic malignancies
Victoria L Doss, Cecilia F P M de Sousa, Elaina Hales, et al.
Journal for Immunotherapy of Cancer
|
October 4, 2023
Ablative radiation alone in stage I lung cancer produces an adaptive systemic immune response: insights from a prospective stud
Khinh Ranh Voong, Peter B Illei, Bradley Presson, et al.
International Journal of Radiation Oncology, Biology, Physics
|
June 25, 2015
Importance of Local Control in Early-Stage Prostate Cancer: Outcomes of Patients With Positive Post-Radiation Therapy Biopsy Results Treated in RTOG 9408
Daniel J Krauss, Chen Hu, Jean-Paul Bahary, et al.
Acta Pharmacologica Sinica
|
May 14, 2020
Osimertinib successfully combats EGFR-negative glioblastoma cells by inhibiting the MAPK pathway
Cheng Chen, Chuan-Dong Cheng, Hong Wu, et al.
Page
of 118